162 related articles for article (PubMed ID: 8690906)
1. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase.
Kwok WW; Domeier ML; Raymond FC; Byers P; Nepom GT
J Immunol; 1996 Mar; 156(6):2171-7. PubMed ID: 8690906
[TBL] [Abstract][Full Text] [Related]
2. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions.
Buckner J; Kwok WW; Nepom B; Nepom GT
J Immunol; 1996 Dec; 157(11):4940-5. PubMed ID: 8943399
[TBL] [Abstract][Full Text] [Related]
3. HLA-DQ polymorphisms are highly selective for peptide binding interactions.
Kwok WW; Nepom GT; Raymond FC
J Immunol; 1995 Sep; 155(5):2468-76. PubMed ID: 7650377
[TBL] [Abstract][Full Text] [Related]
4. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
Bach JM; Otto H; Nepom GT; Jung G; Cohen H; Timsit J; Boitard C; van Endert PM
J Autoimmun; 1997 Aug; 10(4):375-86. PubMed ID: 9237801
[TBL] [Abstract][Full Text] [Related]
5. A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus.
Ettinger RA; Kwok WW
J Immunol; 1998 Mar; 160(5):2365-73. PubMed ID: 9498778
[TBL] [Abstract][Full Text] [Related]
6. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
Vartdal F; Johansen BH; Friede T; Thorpe CJ; Stevanović S; Eriksen JE; Sletten K; Thorsby E; Rammensee HG; Sollid LM
Eur J Immunol; 1996 Nov; 26(11):2764-72. PubMed ID: 8921967
[TBL] [Abstract][Full Text] [Related]
7. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
[TBL] [Abstract][Full Text] [Related]
8. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif.
Herman AE; Tisch RM; Patel SD; Parry SL; Olson J; Noble JA; Cope AP; Cox B; Congia M; McDevitt2 HO
J Immunol; 1999 Dec; 163(11):6275-82. PubMed ID: 10570321
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
[TBL] [Abstract][Full Text] [Related]
10. Definition of a DQ3.1-specific binding motif.
Sidney J; Oseroff C; del Guercio MF; Southwood S; Krieger JI; Ishioka GY; Sakaguchi K; Appella E; Sette A
J Immunol; 1994 May; 152(9):4516-25. PubMed ID: 7512598
[TBL] [Abstract][Full Text] [Related]
11. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ
J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283
[TBL] [Abstract][Full Text] [Related]
12. Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles.
Ettinger RA; Papadopoulos GK; Moustakas AK; Nepom GT; Kwok WW
J Immunol; 2006 Feb; 176(3):1988-98. PubMed ID: 16424231
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the fine specificity of peptide antibodies to HLA-DQ beta-chain molecules.
Petersen JS; Atar D; Karlsen A; Kofod H; Dyrberg T
Biomed Biochim Acta; 1990; 49(12):1223-32. PubMed ID: 1711320
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule.
Kapoerchan VV; Wiesner M; Hillaert U; Drijfhout JW; Overhand M; Alard P; van der Marel GA; Overkleeft HS; Koning F
Mol Immunol; 2010 Feb; 47(5):1091-7. PubMed ID: 19962195
[TBL] [Abstract][Full Text] [Related]
15. The peptide-binding motif of HLA-DR8 shares important structural features with other type 1 diabetes-associated alleles.
Muixí L; Gay M; Muñoz-Torres PM; Guitart C; Cedano J; Abian J; Alvarez I; Jaraquemada D
Genes Immun; 2011 Oct; 12(7):504-12. PubMed ID: 21654843
[TBL] [Abstract][Full Text] [Related]
16. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes.
Yu B; Gauthier L; Hausmann DH; Wucherpfennig KW
Eur J Immunol; 2000 Sep; 30(9):2497-506. PubMed ID: 11009082
[TBL] [Abstract][Full Text] [Related]
17. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).
Godkin A; Friede T; Davenport M; Stevanovic S; Willis A; Jewell D; Hill A; Rammensee HG
Int Immunol; 1997 Jun; 9(6):905-11. PubMed ID: 9199974
[TBL] [Abstract][Full Text] [Related]
18. HLA-DP2: self peptide sequences and binding properties.
Chicz RM; Graziano DF; Trucco M; Strominger JL; Gorga JC
J Immunol; 1997 Nov; 159(10):4935-42. PubMed ID: 9366419
[TBL] [Abstract][Full Text] [Related]
19. HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides.
Ellis RJ; Varela-Calvino R; Tree TI; Peakman M
Immunology; 2005 Nov; 116(3):337-46. PubMed ID: 16236123
[TBL] [Abstract][Full Text] [Related]
20. Determination of the peptide binding motif and high-affinity ligands for HLA-DQ4 using synthetic peptide libraries.
Volz T; Schwarz G; Fleckenstein B; Schepp CP; Haug M; Roth J; Wiesmüller KH; Dannecker GE
Hum Immunol; 2004 Jun; 65(6):594-601. PubMed ID: 15219379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
